featured
Treatment Modifiers Across Different Regimens of Natalizumab Treatment in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurotherapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience
Neurotherapeutics 2024 Feb 26;[EPub Ahead of Print], S Ruggieri, A Ianniello, M Copetti, M Altieri, D Centonze, A Cortese, L De Giglio, R Fantozzi, C Tortorella, C Gasperini, LM Grimaldi, D Landi, GA Marfia, M Mirabella, R Nistri, V Nociti, O Oddo, S Romano, G Salemi, M Salvetti, C Pozzilli, M PetraccaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.